跳至主要内容
临床试验/ACTRN12611000232932
ACTRN12611000232932已完成不适用

In healthy postmenopausal women what are the effects of hydroxyapatite preparations compared with calcium citrate and calcium carbonate on serum calcium and markers of bone turnover?

The University of Auckland0 个研究点目标入组 100 人开始时间: 2011年3月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Female

入选标准

  • Female, postmenopausal 5 years or more (menopause defined as at least 12 months since last period in a woman aged > 45 yrs with intact uterus, or serum oestradiol < 100 pmol/l with FSH > 50 IU/l in younger or hysterectomised woman).

排除标准

  • Past history of coronary heart disease, cerebrovascular disease or peripheral vascular disease, estimated 5-year cardiovascular risk >15%, renal impairment (serum creatinine >0.15 mmol/L), chronic liver disease, untreated hypothyroidism or hyperthyroidism, concurrent major systemic illness (including malignancy), active major gastrointestinal disease, metabolic bone diseases, or serum ALP >normal, primary hyperparathyroidism, current or expected use of oral glucocorticoid drugs during the trial period, current or past use of bisphosphonate therapy in the preceding 2 years, use of hormone replacement therapy within the last 12 months, use of other medication known to cause osteoporosis or interfere with bone metabolism.

研究者

相似试验